News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|May 31, 2019

Reducing Influenza Duration, Related Complications and Healthcare Costs with Novel Antivirals

https://www.pharmacytimes.org/on-demand/ajmc-payer-forum-reducing-influenza-duration-related-complications-and-healthcare-costs-with-novel-antivirals

https://www.pharmacytimes.org/on-demand/ajmc-payer-forum-reducing-influenza-duration-related-complications-and-healthcare-costs-with-novel-antivirals

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Doctor conducting liquid biopsy | Image Credit: syhin_stas - stock.adobe.com

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

ByBrooke McCormick

January 25th 2026

Ultimately, the authors said most patients will have more than one viable treatment option for first-line therapy, meaning that clinicians will need to rely on careful, informed discussions with patients. | Image credit: Eleni - stock.adobe.com

Novel CLL Therapies Prompt New Treatment Considerations

ByJared Kaltwasser

January 24th 2026

Researchers identified 3 overarching themes: a prolonged journey with symptoms, multiple trials of therapy with inadequate control, and diverse experiences with AIT. | Image credit: Volha Zaitsava - stock.adobe.com

Highlighting Gaps in Allergic Rhinitis Care, Allergen Immunotherapy Access

January 23rd 2026

The findings reinforce the need for earlier recognition of scarring alopecias—particularly CCCA—and improved education for clinicians. | Image Credit: cattyphoto - stock.adobe.com

CCCA Associated With Longer Time to Diagnosis Vs Other Scarring Alopecias

January 23rd 2026

Center on Health Equity and Access

Health Equity & Access Weekly Roundup: January 23, 2026

ByGiuliana Grossi

January 23rd 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Trending on AJMC

Congress Unveils Massive Funding Bill to Avert Shutdown

Novel CLL Therapies Prompt New Treatment Considerations

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

Early Data Show Feasibility of in Vivo CAR T Therapy in Multiple Myeloma

Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.